aluates Reports

$ 0.0

Automative

Global Lung Cancer Diagnostic Tests Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-27Y5886

Global Lung Cancer Diagnostic Tests Market Insights Forecast to 2028

BUY CHAPTERS

Global Lung Cancer Diagnostic Tests Market Research Report 2024

Code: QYRE-Auto-27Y5886

Report

August 2024

Pages:82

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Advpharma

AIT Austrian Institute of Technology GmbH

Courtagen Life Sciences Inc

DiagnoCure Inc. (Inactive)

BioMark Diagnostics Inc.

BioMarker Strategies LLC

Emory University

Epigenomics

GlycoZym

HalioDx SAS

Louisville Bioscience, Inc.

Mayo Clinic US

Lung Cancer Diagnostic Tests Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Lung Cancer Diagnostic Tests Market

The global Lung Cancer Diagnostic Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Diagnostic Tests.

Report Scope

The Lung Cancer Diagnostic Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Cancer Diagnostic Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Diagnostic Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Cancer Diagnostic Tests Market Report

Report Metric	Details
Report Name	Lung Cancer Diagnostic Tests Market
CAGR	5%
Segment by Type	Immunoassays Flow Cytometry Rapid Tests Molecular Assays Tissue Arrays Circulating Tumor Cells Pharmacodiagnostics Biomarkers Other Diagnostics Methods
Segment by Application	Precision Medicine Personalized Medicine Cancer Monitoring
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Advpharma Inc, AIT Austrian Institute of Technology GmbH, Courtagen Life Sciences Inc, DiagnoCure Inc. (Inactive), BioMark Diagnostics Inc., BioMarker Strategies LLC, Emory University, Epigenomics AG, GlycoZym, HalioDx SAS, Louisville Bioscience, Inc., Mayo Clinic US
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Diagnostic Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lung Cancer Diagnostic Tests Market report?

Ans: The main players in the Lung Cancer Diagnostic Tests Market are Advpharma Inc, AIT Austrian Institute of Technology GmbH, Courtagen Life Sciences Inc, DiagnoCure Inc. (Inactive), BioMark Diagnostics Inc., BioMarker Strategies LLC, Emory University, Epigenomics AG, GlycoZym, HalioDx SAS, Louisville Bioscience, Inc., Mayo Clinic US

What are the Application segmentation covered in the Lung Cancer Diagnostic Tests Market report?

Ans: The Applications covered in the Lung Cancer Diagnostic Tests Market report are Precision Medicine, Personalized Medicine, Cancer Monitoring

What are the Type segmentation covered in the Lung Cancer Diagnostic Tests Market report?

Ans: The Types covered in the Lung Cancer Diagnostic Tests Market report are Immunoassays, Flow Cytometry, Rapid Tests, Molecular Assays, Tissue Arrays, Circulating Tumor Cells, Pharmacodiagnostics, Biomarkers, Other Diagnostics Methods

Recommended Reports

Lung Cancer Diagnostics

Cancer Diagnostic Markets

Diagnostic Technology Trends

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immunoassays

1.2.3 Flow Cytometry

1.2.4 Rapid Tests

1.2.5 Molecular Assays

1.2.6 Tissue Arrays

1.2.7 Circulating Tumor Cells

1.2.8 Pharmacodiagnostics

1.2.9 Biomarkers

1.2.10 Other Diagnostics Methods

1.3 Market by Application

1.3.1 Global Lung Cancer Diagnostic Tests Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Precision Medicine

1.3.3 Personalized Medicine

1.3.4 Cancer Monitoring

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Diagnostic Tests Market Perspective (2019-2030)

2.2 Lung Cancer Diagnostic Tests Growth Trends by Region

2.2.1 Global Lung Cancer Diagnostic Tests Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Lung Cancer Diagnostic Tests Historic Market Size by Region (2019-2024)

2.2.3 Lung Cancer Diagnostic Tests Forecasted Market Size by Region (2025-2030)

2.3 Lung Cancer Diagnostic Tests Market Dynamics

2.3.1 Lung Cancer Diagnostic Tests Industry Trends

2.3.2 Lung Cancer Diagnostic Tests Market Drivers

2.3.3 Lung Cancer Diagnostic Tests Market Challenges

2.3.4 Lung Cancer Diagnostic Tests Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue

3.1.1 Global Top Lung Cancer Diagnostic Tests Players by Revenue (2019-2024)

3.1.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Players (2019-2024)

3.2 Global Lung Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Lung Cancer Diagnostic Tests Revenue

3.4 Global Lung Cancer Diagnostic Tests Market Concentration Ratio

3.4.1 Global Lung Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostic Tests Revenue in 2023

3.5 Lung Cancer Diagnostic Tests Key Players Head office and Area Served

3.6 Key Players Lung Cancer Diagnostic Tests Product Solution and Service

3.7 Date of Enter into Lung Cancer Diagnostic Tests Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Diagnostic Tests Breakdown Data by Type

4.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Type (2019-2024)

4.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Type (2025-2030)

5 Lung Cancer Diagnostic Tests Breakdown Data by Application

5.1 Global Lung Cancer Diagnostic Tests Historic Market Size by Application (2019-2024)

5.2 Global Lung Cancer Diagnostic Tests Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Lung Cancer Diagnostic Tests Market Size (2019-2030)

6.2 North America Lung Cancer Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Lung Cancer Diagnostic Tests Market Size by Country (2019-2024)

6.4 North America Lung Cancer Diagnostic Tests Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Diagnostic Tests Market Size (2019-2030)

7.2 Europe Lung Cancer Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Lung Cancer Diagnostic Tests Market Size by Country (2019-2024)

7.4 Europe Lung Cancer Diagnostic Tests Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (2019-2030)

8.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2019-2024)

8.4 Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Diagnostic Tests Market Size (2019-2030)

9.2 Latin America Lung Cancer Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Lung Cancer Diagnostic Tests Market Size by Country (2019-2024)

9.4 Latin America Lung Cancer Diagnostic Tests Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Diagnostic Tests Market Size (2019-2030)

10.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2019-2024)

10.4 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Advpharma Inc

11.1.1 Advpharma Inc Company Detail

11.1.2 Advpharma Inc Business Overview

11.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Introduction

11.1.4 Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.1.5 Advpharma Inc Recent Development

11.2 AIT Austrian Institute of Technology GmbH

11.2.1 AIT Austrian Institute of Technology GmbH Company Detail

11.2.2 AIT Austrian Institute of Technology GmbH Business Overview

11.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Introduction

11.2.4 AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.2.5 AIT Austrian Institute of Technology GmbH Recent Development

11.3 Courtagen Life Sciences Inc

11.3.1 Courtagen Life Sciences Inc Company Detail

11.3.2 Courtagen Life Sciences Inc Business Overview

11.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Introduction

11.3.4 Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.3.5 Courtagen Life Sciences Inc Recent Development

11.4 DiagnoCure Inc. (Inactive)

11.4.1 DiagnoCure Inc. (Inactive) Company Detail

11.4.2 DiagnoCure Inc. (Inactive) Business Overview

11.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Introduction

11.4.4 DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.4.5 DiagnoCure Inc. (Inactive) Recent Development

11.5 BioMark Diagnostics Inc.

11.5.1 BioMark Diagnostics Inc. Company Detail

11.5.2 BioMark Diagnostics Inc. Business Overview

11.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Introduction

11.5.4 BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.5.5 BioMark Diagnostics Inc. Recent Development

11.6 BioMarker Strategies LLC

11.6.1 BioMarker Strategies LLC Company Detail

11.6.2 BioMarker Strategies LLC Business Overview

11.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Introduction

11.6.4 BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.6.5 BioMarker Strategies LLC Recent Development

11.7 Emory University

11.7.1 Emory University Company Detail

11.7.2 Emory University Business Overview

11.7.3 Emory University Lung Cancer Diagnostic Tests Introduction

11.7.4 Emory University Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.7.5 Emory University Recent Development

11.8 Epigenomics AG

11.8.1 Epigenomics AG Company Detail

11.8.2 Epigenomics AG Business Overview

11.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Introduction

11.8.4 Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.8.5 Epigenomics AG Recent Development

11.9 GlycoZym

11.9.1 GlycoZym Company Detail

11.9.2 GlycoZym Business Overview

11.9.3 GlycoZym Lung Cancer Diagnostic Tests Introduction

11.9.4 GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.9.5 GlycoZym Recent Development

11.10 HalioDx SAS

11.10.1 HalioDx SAS Company Detail

11.10.2 HalioDx SAS Business Overview

11.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Introduction

11.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.10.5 HalioDx SAS Recent Development

11.11 Louisville Bioscience, Inc.

11.11.1 Louisville Bioscience, Inc. Company Detail

11.11.2 Louisville Bioscience, Inc. Business Overview

11.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Introduction

11.11.4 Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.11.5 Louisville Bioscience, Inc. Recent Development

11.12 Mayo Clinic US

11.12.1 Mayo Clinic US Company Detail

11.12.2 Mayo Clinic US Business Overview

11.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Introduction

11.12.4 Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2019-2024)

11.12.5 Mayo Clinic US Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Advpharma

AIT Austrian Institute of Technology GmbH

Courtagen Life Sciences Inc

DiagnoCure Inc. (Inactive)

BioMark Diagnostics Inc.

BioMarker Strategies LLC

Emory University

Epigenomics

GlycoZym

HalioDx SAS

Louisville Bioscience, Inc.

Mayo Clinic US

List of Tables

Table 1. Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immunoassays

Table 3. Key Players of Flow Cytometry

Table 4. Key Players of Rapid Tests

Table 5. Key Players of Molecular Assays

Table 6. Key Players of Tissue Arrays

Table 7. Key Players of Circulating Tumor Cells

Table 8. Key Players of Pharmacodiagnostics

Table 9. Key Players of Biomarkers

Table 10. Key Players of Other Diagnostics Methods

Table 11. Global Lung Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Lung Cancer Diagnostic Tests Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 13. Global Lung Cancer Diagnostic Tests Market Size by Region (2019-2024) & (US$ Million)

Table 14. Global Lung Cancer Diagnostic Tests Market Share by Region (2019-2024)

Table 15. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 16. Global Lung Cancer Diagnostic Tests Market Share by Region (2025-2030)

Table 17. Lung Cancer Diagnostic Tests Market Trends

Table 18. Lung Cancer Diagnostic Tests Market Drivers

Table 19. Lung Cancer Diagnostic Tests Market Challenges

Table 20. Lung Cancer Diagnostic Tests Market Restraints

Table 21. Global Lung Cancer Diagnostic Tests Revenue by Players (2019-2024) & (US$ Million)

Table 22. Global Lung Cancer Diagnostic Tests Market Share by Players (2019-2024)

Table 23. Global Top Lung Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic Tests as of 2023)

Table 24. Ranking of Global Top Lung Cancer Diagnostic Tests Companies by Revenue (US$ Million) in 2023

Table 25. Global 5 Largest Players Market Share by Lung Cancer Diagnostic Tests Revenue (CR5 and HHI) & (2019-2024)

Table 26. Key Players Headquarters and Area Served

Table 27. Key Players Lung Cancer Diagnostic Tests Product Solution and Service

Table 28. Date of Enter into Lung Cancer Diagnostic Tests Market

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Lung Cancer Diagnostic Tests Market Size by Type (2019-2024) & (US$ Million)

Table 31. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2019-2024)

Table 32. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 33. Global Lung Cancer Diagnostic Tests Revenue Market Share by Type (2025-2030)

Table 34. Global Lung Cancer Diagnostic Tests Market Size by Application (2019-2024) & (US$ Million)

Table 35. Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2019-2024)

Table 36. Global Lung Cancer Diagnostic Tests Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 37. Global Lung Cancer Diagnostic Tests Revenue Market Share by Application (2025-2030)

Table 38. North America Lung Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Lung Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Lung Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Lung Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Europe Lung Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)

Table 43. Europe Lung Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)

Table 44. Asia-Pacific Lung Cancer Diagnostic Tests Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 45. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2019-2024) & (US$ Million)

Table 46. Asia-Pacific Lung Cancer Diagnostic Tests Market Size by Region (2025-2030) & (US$ Million)

Table 47. Latin America Lung Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Latin America Lung Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)

Table 49. Latin America Lung Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)

Table 50. Middle East & Africa Lung Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 51. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)

Table 52. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)

Table 53. Advpharma Inc Company Detail

Table 54. Advpharma Inc Business Overview

Table 55. Advpharma Inc Lung Cancer Diagnostic Tests Product

Table 56. Advpharma Inc Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 57. Advpharma Inc Recent Development

Table 58. AIT Austrian Institute of Technology GmbH Company Detail

Table 59. AIT Austrian Institute of Technology GmbH Business Overview

Table 60. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product

Table 61. AIT Austrian Institute of Technology GmbH Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 62. AIT Austrian Institute of Technology GmbH Recent Development

Table 63. Courtagen Life Sciences Inc Company Detail

Table 64. Courtagen Life Sciences Inc Business Overview

Table 65. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product

Table 66. Courtagen Life Sciences Inc Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 67. Courtagen Life Sciences Inc Recent Development

Table 68. DiagnoCure Inc. (Inactive) Company Detail

Table 69. DiagnoCure Inc. (Inactive) Business Overview

Table 70. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product

Table 71. DiagnoCure Inc. (Inactive) Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 72. DiagnoCure Inc. (Inactive) Recent Development

Table 73. BioMark Diagnostics Inc. Company Detail

Table 74. BioMark Diagnostics Inc. Business Overview

Table 75. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product

Table 76. BioMark Diagnostics Inc. Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 77. BioMark Diagnostics Inc. Recent Development

Table 78. BioMarker Strategies LLC Company Detail

Table 79. BioMarker Strategies LLC Business Overview

Table 80. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product

Table 81. BioMarker Strategies LLC Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 82. BioMarker Strategies LLC Recent Development

Table 83. Emory University Company Detail

Table 84. Emory University Business Overview

Table 85. Emory University Lung Cancer Diagnostic Tests Product

Table 86. Emory University Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 87. Emory University Recent Development

Table 88. Epigenomics AG Company Detail

Table 89. Epigenomics AG Business Overview

Table 90. Epigenomics AG Lung Cancer Diagnostic Tests Product

Table 91. Epigenomics AG Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 92. Epigenomics AG Recent Development

Table 93. GlycoZym Company Detail

Table 94. GlycoZym Business Overview

Table 95. GlycoZym Lung Cancer Diagnostic Tests Product

Table 96. GlycoZym Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 97. GlycoZym Recent Development

Table 98. HalioDx SAS Company Detail

Table 99. HalioDx SAS Business Overview

Table 100. HalioDx SAS Lung Cancer Diagnostic Tests Product

Table 101. HalioDx SAS Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 102. HalioDx SAS Recent Development

Table 103. Louisville Bioscience, Inc. Company Detail

Table 104. Louisville Bioscience, Inc. Business Overview

Table 105. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product

Table 106. Louisville Bioscience, Inc. Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 107. Louisville Bioscience, Inc. Recent Development

Table 108. Mayo Clinic US Company Detail

Table 109. Mayo Clinic US Business Overview

Table 110. Mayo Clinic US Lung Cancer Diagnostic Tests Product

Table 111. Mayo Clinic US Revenue in Lung Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 112. Mayo Clinic US Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Lung Cancer Diagnostic Tests Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Lung Cancer Diagnostic Tests Market Share by Type: 2023 VS 2030

Figure 3. Immunoassays Features

Figure 4. Flow Cytometry Features

Figure 5. Rapid Tests Features

Figure 6. Molecular Assays Features

Figure 7. Tissue Arrays Features

Figure 8. Circulating Tumor Cells Features

Figure 9. Pharmacodiagnostics Features

Figure 10. Biomarkers Features

Figure 11. Other Diagnostics Methods Features

Figure 12. Global Lung Cancer Diagnostic Tests Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 13. Global Lung Cancer Diagnostic Tests Market Share by Application: 2023 VS 2030

Figure 14. Precision Medicine Case Studies

Figure 15. Personalized Medicine Case Studies

Figure 16. Cancer Monitoring Case Studies

Figure 17. Lung Cancer Diagnostic Tests Report Years Considered

Figure 18. Global Lung Cancer Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 19. Global Lung Cancer Diagnostic Tests Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 20. Global Lung Cancer Diagnostic Tests Market Share by Region: 2023 VS 2030

Figure 21. Global Lung Cancer Diagnostic Tests Market Share by Players in 2023

Figure 22. Global Top Lung Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic Tests as of 2023)

Figure 23. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostic Tests Revenue in 2023

Figure 24. North America Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. North America Lung Cancer Diagnostic Tests Market Share by Country (2019-2030)

Figure 26. United States Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Canada Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Europe Lung Cancer Diagnostic Tests Market Share by Country (2019-2030)

Figure 30. Germany Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia-Pacific Lung Cancer Diagnostic Tests Market Share by Region (2019-2030)

Figure 38. China Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Japan Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. South Korea Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. India Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Australia Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Latin America Lung Cancer Diagnostic Tests Market Share by Country (2019-2030)

Figure 46. Mexico Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Brazil Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Lung Cancer Diagnostic Tests Market Share by Country (2019-2030)

Figure 50. Turkey Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Lung Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Advpharma Inc Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 53. AIT Austrian Institute of Technology GmbH Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 54. Courtagen Life Sciences Inc Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 55. DiagnoCure Inc. (Inactive) Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 56. BioMark Diagnostics Inc. Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 57. BioMarker Strategies LLC Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 58. Emory University Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 59. Epigenomics AG Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 60. GlycoZym Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 61. HalioDx SAS Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 62. Louisville Bioscience, Inc. Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 63. Mayo Clinic US Revenue Growth Rate in Lung Cancer Diagnostic Tests Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Diagnostic Kit Market Research Report 2024

Global Cervical Cancer Diagnostic Testing Devices Market Research Report 2025

Global Cancer Tissue Diagnostics Market Research Report 2024

Global Gynecological Cancer Diagnostics Market Research Report 2025

Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Brain Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Next Generation Gynecological Cancer Diagnostics Market Research Report 2024

Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non invasive Cancer Diagnosis Market Research Report 2024

Skin Cancer Diagnostics Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

Global At Home Diagnostic Testing Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions